All In MedTech

Device Trial Radar · NCT07611708

Lubricin-inspired Osteoarthritis Treatment: a Unique Solution

First in Human Safety Evaluation of a Novel Polymer for Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

25

Planned (sponsor's estimate)

Start

Nov 1, 2026

Primary completion

Mar 2028

Study completion Jun 2028

Sponsor

Lead sponsor
Pleryon Therapeutics (Hangzhou) LimitedNot on our public-company list
Sponsor type
Industry
First posted
May 28, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This goal of this open label study is to evaluate the safety and tolerability of a single intra-articular administration of ABR1 in adults with knee osteoarthritis with a KL grade from 2 to 4. The primary questions it aims to answer are: 1. Is ABR1 safe to use as an intraarticular injection for participants with knee osteoarthritis? 2. What medical problems do participants have after receiving a single injection of ABR1? Participants will receive a single injection of ABR1 to the knee with osteoarthritis. Participants will 1. Keep a stable pain treatment regimen 2. Visit the clinic at 1 week, 4 weeks, 8 weeks, and 12 weeks post injection 3. Keep a diary of their symptoms and number of times they use a rescue medication for their knee pain.

Conditions

  • Osteo Arthritis of the Knee

Interventions

  • ABR1Device

    Received a single dose of ABR1

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of adverse eventsTime frame: from the day receiving study intervention (day 0) to 12 weeks after study intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Royal North Shore Hospital

    Sydney, New South Wales, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.